Chennai, 17th May 2024: Apollo Proton Cancer Centre (APCC), South Asia’s first and largest proton therapy announces the launch of the Robotic Surgery Programme for Ovarian Cancers and the successful completion of India’s First Robotic Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in two unique cases of advanced ovarian cancers. These medical milestones mark a significant advancement in the regional cancer treatment landscape, offering new hope and improved care standards for patients battling this severe illness.
Apollo Proton Cancer Centre Announces India’s First Robotic Surgery Program for Ovarian Cancer
Related Posts
BD India’s Concerted Commitment Towards Creating Awareness About Venous Diseases
24th July 2024 New Delhi, Delhi, India To create awareness and enable knowledge-sharing around Venous diseases, in order to drive better patient care BD (Becton, Dickinson, and Company) conducted roadshows across…
Demystifying Varicose Veins: Sri Ramakrishna Hospital’s Vascular Specialists Illuminate the Path to Effective Management
22nd July 2024 Coimbatore, Tamil Nadu, India Dispelling misconceptions surrounding varicose veins, experts at Sri Ramakrishna Hospital delve into the condition’s nuances, offering insights into symptoms, symptom management, and prevention strategies.…